New angiogenic agents and non-small cell lung cancer: current results and future development.
- Published in:
- Targeted Oncology, 2007, v. 2, n. 4, p. 211, doi. 10.1007/s11523-007-0060-7
- By:
- Publication type:
- Article
Works matching IS 17762596 AND DT 2007 AND VI 2 AND IP 4
Results: 7
1
2
Targeted therapy in hormone refractory prostate cancer.
- Published in:
- Targeted Oncology, 2007, v. 2, n. 4, p. 235, doi. 10.1007/s11523-007-0063-4
- By:
- Publication type:
- Article
3
Effect of cetuximab in recurrent and refractory squamous cell carcinoma of the head and neck (SCCHN): a case report.
- Published in:
- Targeted Oncology, 2007, v. 2, n. 4, p. 253, doi. 10.1007/s11523-007-0061-6
- By:
- Publication type:
- Article
4
Molecular targeted therapy for advanced hepatocellular carcinoma.
- Published in:
- Targeted Oncology, 2007, v. 2, n. 4, p. 199, doi. 10.1007/s11523-007-0058-1
- By:
- Publication type:
- Article
5
The intersection of sunitinib with the immunosuppressive microenvironment of renal cell carcinoma: implications for future therapeutics.
- Published in:
- Targeted Oncology, 2007, v. 2, n. 4, p. 225, doi. 10.1007/s11523-007-0064-3
- By:
- Publication type:
- Article
6
Combining targeted therapies.
- Published in:
- Targeted Oncology, 2007, v. 2, n. 4, p. 241, doi. 10.1007/s11523-007-0062-5
- By:
- Publication type:
- Article
7
Beyond outstanding results with VEGFR/PDGFR inhibitors in advanced hepatocellular carcinoma: can imaging help where biomarkers keep us waiting?
- Published in:
- 2007
- By:
- Publication type:
- Editorial